About this trial
In our study, investigators plan to compare the preoperative RF and genicular nerve ablation approach in patients who underwent TKA(Total Knee Arthroplasty) using the Fast-Track protocol in terms of meeting postoperative pain, function and early discharge criteria.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Being between the ages of 40 and 85,
Being able to understand verbal and written information given in Turkish,
Being able to speak and understand Turkish,
Being subjected to unilateral TKA surgery due to the diagnosis of Primary Knee osteoarthritis
Disqualifiers
Patients planned for revision knee prosthesis surgery,
Patients previously diagnosed with psychiatric disorders,
Patients who have undergone major surgery on the extremity where TKA will be applied,
Patients with comorbid diseases such as rheumatoid arthritis or cancer,
Trial population
Inclusion Criteria: * Being between the ages of 40 and 85, * Being able to understand verbal and written information given in Turkish, * Being able to speak and understand Turkish, * Being subjected to unilateral TKA surgery due to the diagnosis of Primary Knee osteoarthritis
Trial design
Case-control
Prospective
Treatments tested in this trial
Genicular nerve Radiofrequency Ablation block
Procedure/SurgeryGenicular nerve Radiofrequency Ablation block
Treatment groups
Trial outcomes
Primary outcomes
Pain preoperative
Visual Analog Scale used to assess pain
Pain postoperative 1
Visual Analog Scale used to assess pain
Pain postoperative 2
Visual Analog Scale used to assess pain
Knee Range of Motion preoperative
Digital goniometer used to assess knee range of motion
Secondary outcomes
Length of operation time
Length of operation time is measured in minutes during the surgery
Amount of blood loss
Amount of blood loss is measured from the suction drainage (unit-milliliters)
postoperative component alignments
Long leg radiographs of the patients are evaluated postoperatively by using a digital orthopedic templating software-Materialise OrthoView (OrthoView version 7, Materialise HQ, Technologielaan 15 3001 Leuven, Belgium).
Sponsors and contacts
Click on the lead sponsor to view all of their trials.